Kim Kelderman Power - 15 Aug 2023 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role: Pres. Diagnostics & Genom
Signature: /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol: TECH
Transactions as of: 15 Aug 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 14 Dec 2023, 18:13:26 UTC
Date Of Original Report: 17 Aug 2023
Previous filing: 08 Aug 2023
Next filing: 28 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECH	Restricted Stock Units	Award	$0	+8,873		$0.000000	8,873	15 Aug 2023	Common Stock	8,873		Direct	F1, F2
transaction	TECH	Stock Options (Right to Buy)	Award	$0	+23,881		$0.000000	23,881	15 Aug 2023	Common Stock	23,881	$84.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2	Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of restricted stock units and performance options being granted.